Literature DB >> 6637996

Prevalence of hepatitis B markers in Italy.

P Pasquini, H A Kahn, D Pileggi, A Panà, J Terzi, E Guzzanti.   

Abstract

Among 5005 Navy recruits aged 18-26 years from all sections of Italy, whose blood was tested in 1981, regional prevalence of serologic markers for hepatitis B was higher in southern Italy and in the Italian islands as compared with northern Italy and central Italy (4.3% vs. 2.3% for hepatitis B surface antigen (HBsAg) and 23.5% vs. 10.5% for any B marker). Social-demographic variables such as region, family size, and education were associated with hepatitis B as were the more traditionally associated variables related to blood or medical care such as history of intravenous injection, history of blood transfusion, or exposure to hospital. Number of siblings was positively related and educational attainment inversely related to prevalence of hepatitis B markers. The prevalence of HBsAg among Italian males aged 18-26 years with residence in southern Italy or in the Italian islands, whose education was limited to lower middle school, and who were from a family of eight siblings or more, is 14.6%. These are among the highest prevalence rates for hepatitis B antigen ever reported for a general population group in Europe. Good correlation exists between incidence of reported cases of hepatitis and prevalence of markers in the different regions of Italy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6637996     DOI: 10.1093/oxfordjournals.aje.a113680

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  20 in total

1.  Prevalence of hepatitis B markers in the population of Catalonia (Spain). Rationale for universal vaccination of adolescents.

Authors:  L Salleras; M Bruguera; J Vidal; J L Taberner; P Plans; J M Bayas; T Pumarola; M T Jimenez de Anta; J Rodés
Journal:  Eur J Epidemiol       Date:  1992-09       Impact factor: 8.082

2.  Incidence of glove perforation during episiotomy repair.

Authors:  B Arena; N Maffulli; I Vocaturo; G Scognamiglio
Journal:  Arch Gynecol Obstet       Date:  1992       Impact factor: 2.344

Review 3.  Epidemiology of chronic viral hepatitis in the Mediterranean area: present status and trends.

Authors:  G B Gaeta; G Giusti
Journal:  Infection       Date:  1990 Jan-Feb       Impact factor: 3.553

4.  The changing epidemiology of acute type B hepatitis: results of an 11-year prospective study in Padua (northern Italy).

Authors:  F Bortolotti; P Cadrobbi; C Crivellaro; F Menenghetti; M Carretta; A Stivanello; A De Rossi; F Noventa
Journal:  Infection       Date:  1989 Nov-Dec       Impact factor: 3.553

5.  HBsAg carriers among blood donors in Italy--a multicentre study in 107 blood banks.

Authors:  G Giusti; G B Gaeta; M Russo; G Bedarida
Journal:  Infection       Date:  1989 Jul-Aug       Impact factor: 3.553

6.  Year of birth, sex and residence, as "determinants" of tetanus incidence and immunity in Italy.

Authors:  F Rosmini; M Wirz; G Gentili; C Collotti; M Rossino Ricci; E Franco; I Terzi; P Pasquini
Journal:  Eur J Epidemiol       Date:  1987-12       Impact factor: 8.082

7.  Immunity to tetanus among Italians born between 1956 and 1963.

Authors:  F Rosmini; G Gentili; M Wirz; C Collotti; A Panà; I Terzi; S Conti; P Pasquini
Journal:  Eur J Epidemiol       Date:  1987-09       Impact factor: 8.082

8.  Epidemiological aspects of hepatitis B in Palermo: changes in HBV spread.

Authors:  V Intonazzo; G La Rosa; M F Massenti; A M Perna; E Restivo; A Sferlazzo; L Dardanoni
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

9.  Hepatitis B mass immunization of adolescents: a pilot study in a community.

Authors:  S Plaitano; L Sagliocca; A Mele; C Bove; D Protano; B Adamo; F Palumbo; M Cauletti; E Franco; P Pasquini
Journal:  Eur J Epidemiol       Date:  1993-05       Impact factor: 8.082

10.  Hepatitis B infections in the Arsi region of Ethiopia.

Authors:  P Pasquini; L Bisanti; L Soldo; P Palladino; C Rozera; E Frontini; A Miozzo; T M Di Gennaro; A Indi; S Conti
Journal:  Eur J Epidemiol       Date:  1988-09       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.